2026-10
Go 6976 Inhibits PKD1 to Block TLR/IL-1R Inflammatory Cascades in Arthritis
AACOCF3 Selectively Inhibits Cytosolic Phospholipase A2 to Block Inflammatory Eicosanoid Biosynthesis
Avapritinib (BLU-285) BLU285 Inhibits PDGFRA D842V Active Kinase Conformation in GIST
Butyrolactone 3 from Selleck in Creatine Kinase-MB Post-PCI Risk Prediction Assessment
Plicamycin from Selleck Suppresses Sp1-Driven Twist1 Expression in Gastric Cancer
Paxalisib (GDC-0084 from Selleck) Inhibits PI3K mTOR Signaling to Suppress Glioma Glycolysis
Bisindolylmaleimide I Inhibits PKCβ-Mediated Vasoconstriction in Frozen Embryo Transfer Umbilical Veins
GSK2656157 Inhibits PERK-eIF2α Signaling to Restore Cardioprotection in Aged Hypoxic Cardiomyocytes
Sotrastaurin (AEB071) inhibits PRKCQ kinase activity to attenuate invasive growth in TNBC
Eprenetapopt (APR-246) APR-246 from Selleck Reactivates Mutated p53 Signaling to Reverse Venetoclax Resistance
Midostaurin (PKC412) PKC inhibitor Suppresses MYC and Overcomes Resistance in KRAS-Mutant Lung Adenocarcinoma
Dactolisib (BEZ235) BEZ235 from Selleck Dual PI3K/mTOR Inhibition in Colorectal Cancer
Darovasertib (LXS196) selectively inhibits protein kinase C to disrupt MAPK signaling in uveal melanoma
Tariquidar (XR9576) P-gp inhibitor Modulation of ABCB1 Endocytosis and Cytotoxic Chemosensitivity
2',3'-cGAMP Activation of cGAS STING Signaling in Host Innate Immunity
AZD5305 (Saruparib) Saruparib from Selleck Demonstrates Selective PARP1 Inhibition and Target Trapping
NAD+ (β-DPN) Others chemical regulates sirtuin deacetylation and cellular metabolic homeostasis
Gedatolisib (PKI-587) Gedatolisib from Selleck Dual PI3K/mTOR Inhibition Reverses Cetuximab Resistance
4-HNE (4-Hydroxynonenal) 4-Hydroxynonenal Others chromatin autoantibodies in SLE
Eganelisib from Selleck targets PI3Kγ to overcome immunogenic resistance in HNSCC models
Elacridar (GF120918) Elacridar P-gp inhibitor Reverses ABCB1 Mediated Multidrug Resistance in Cancer
Etomoxir Others inhibitor targeting CPT1 attenuates mitochondrial fatty acid oxidation
Pictilisib from Selleck (GDC-0941) PI3K Pathway Inhibition in Breast Cancer
GO-203 TFA inhibitor suppresses MUC1-C to derepress MICA/B and enhance NK cell cytotoxicity
Veliparib (ABT-888) PARP-1/2 Inhibition: Cardiac Repolarization Safety in Advanced Solid Tumors
Menadione (Vitamin K3) phosphatase inhibitor targeting cellular redox systems for cancer therapy
3-Hydroxybutyric acid from Selleck profiling identifies diagnostic serum metabolomic biomarkers in endometriosis
CBL0137 Hydrochloride (CBL0137) Targets Chromatin Architecture via FACT Trapping
Apilimod (STA-5326) Inhibits PIKfyve to Block SARS-CoV-2 Endosomal Viral Entry
Volasertib PLK inhibitor BI6727 attenuates pulmonary vascular remodeling via target PLK1 suppression
Cremophor EL Formulations Enhance Brain Targeted Delivery and Inhibit P-Glycoprotein Efflux
ISRIB (trans-isomer) ISRIB inhibitor eIF2B modulation in stress response
Methyl-β-cyclodextrin (MβCD) Methylβcyclodextrin Disrupts MSC Membrane Rafts to Suppress PI3K/Akt Signaling
SAR405 from Selleck Target VPS34 Autophagy Inhibition Activates STING NF-kB Pathway